Radiodermatitis Market

Radiodermatitis Market

Radiodermatitis Market Forecasts to 2030 - Global Analysis By Product (Topical, Oral Drugs and Dressings), Stage (Mild, Moderate and Severe), Distribution Channel and By Geography

4.1 (46 reviews)
4.1 (46 reviews)
Published: 2024 ID: SMRC26422

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Radiodermatitis Market is accounted for $458.3 million in 2024 and is expected to reach $628.4 million by 2030 growing at a CAGR of 5.4% during the forecast period. Radiodermatitis is a skin condition caused by radiation therapy, commonly experienced by cancer patients. It manifests as redness, irritation, peeling, and sometimes ulceration of the skin. The severity ranges from mild to severe, impacting the quality of life and potentially disrupting cancer treatment. Effective management includes topical treatments, dressings, and preventive measures to mitigate symptoms.

According to the National Cancer Institute (NCI), radiation dermatitis occurs in approximately 95% of patients receiving radiation therapy.

Market Dynamics:


Increasing incidence of cancer

The increasing incidence of cancer serves as a significant driver in the radiodermatitis market. With cancer being a leading cause of mortality worldwide, the utilization of radiation therapy as a crucial treatment modality is rising. As more individuals undergo radiation therapy for various cancer types, the prevalence of radiodermatitis, a common side effect, also escalates. This heightened demand for radiodermatitis management solutions, including skincare products and treatments, propels market growth, driving innovation and investment in this sector.


High treatment costs

The expenses associated with managing radiodermatitis, including medications, skincare products, and supportive care, impose a financial burden on patients. Additionally, the cumulative costs of radiation therapy sessions exacerbate the economic strain. For many patients, especially those without adequate insurance coverage or financial resources, the affordability of treatments becomes a significant concern. This barrier may limit access to optimal care and adherence to treatment regimens, impacting overall patient outcomes and market growth.


Growing healthcare infrastructure

Improved healthcare facilities, particularly in emerging economies, enhance access to diagnosis, treatment, and supportive care for radiodermatitis patients. With the establishment of specialized clinics, radiation oncology centers, and dermatology services, individuals can receive timely and comprehensive management for radiodermatitis. Moreover, enhanced infrastructure fosters research and development activities, facilitating the introduction of innovative treatment modalities and skincare products, ultimately driving market growth and improving patient outcomes.


Alternative therapies

Alternative therapies pose a threat to the radiodermatitis market as they offer perceived natural or non-pharmaceutical remedies for managing skin-related side effects of radiation therapy. These therapies, ranging from herbal remedies to homeopathic treatments, may attract patients seeking gentler or more holistic approaches. Consequently, they can divert attention and demand away from conventional medical interventions and pharmaceutical products, impacting their competitiveness and market growth.

Covid-19 Impact: 

The COVID-19 pandemic has impacted the radiodermatitis market by disrupting healthcare services, delaying non-urgent treatments, and shifting focus towards managing the virus. This has led to a temporary slowdown in radiodermatitis diagnosis and treatment procedures. However, as healthcare systems stabilize and prioritize cancer care, the market is expected to rebound, driven by pent-up demand and ongoing advancements in radiodermatitis management.

The topical segment is expected to be the largest during the forecast period

During the forecast period, the topical segment is poised to emerge as the largest in the radiodermatitis market. This prominence is fueled by various factors, such as the convenience of topical treatments, their ease of application, and their effectiveness in managing radiodermatitis symptoms. Moreover, advancements in topical formulations, including the development of novel compounds and delivery systems, are enhancing their therapeutic efficacy. With an increasing focus on patient comfort and adherence, the demand for topical treatments is expected to witness substantial growth in the coming years.

The online pharmacy segment is expected to have the highest CAGR during the forecast period 

The online pharmacy segment is forecasted to experience lucrative growth in the radiodermatitis market during the projected period. This surge is primarily driven by the increasing adoption of e-commerce platforms for purchasing pharmaceutical products. Factors such as convenience, accessibility, and a wide range of product options contribute to the segment's rapid growth. Additionally, the growing trend of telemedicine and digital healthcare services further propels the demand for radiodermatitis treatments through online pharmacies, fostering market expansion.

Region with largest share:

The Asia Pacific is projected to hold the highest market share in the vaccine adjuvant market due to its large population, increasing prevalence of infectious diseases, and rising awareness about vaccination benefits. Additionally, government initiatives and investments in healthcare infrastructure, coupled with the presence of key market players and an expanding biopharmaceutical industry, contribute to market growth. The region's focus on innovative research and development, along with favorable regulatory environments, further drives the demand in Asia Pacific region.

Region with highest CAGR:

The Asia Pacific region is anticipated to exhibit the highest CAGR in the radiodermatitis market over the forecast period. This projection is attributed to several factors, including rising cancer incidence, increased adoption of radiation therapy, expanding healthcare infrastructure, and growing awareness about radiodermatitis management. Additionally, advancements in healthcare technology and government initiatives to improve cancer care are expected to drive market growth in this region.

Key players in the market

Some of the key players in Radiodermatitis Market include 3M Company, Acelity L.P. Inc., Alliqua Biomedical, Inc., B. Braun Melsungen AG, BMG Pharma S.p.A., Cardinal Health, Inc., Coloplast A/S, Convatec Group Plc, DermaRite Industries, LLC, GlaxoSmithKline plc, Hollister Incorporated, Integra Lifesciences Holdings Corporation, Medline Industries, Inc., MiMedx Group, Inc., Mölnlycke Health Care AB, Pfizer Inc., Radiation Products Design Inc., Smith & Nephew plc, and Stratpharma AG.

Key Developments:

In May 2024, 3M has cut the ribbon on a new 90,000-square-foot expansion at the company's facility in Valley, Nebraska that will increase the plant's manufacturing capacity and add new jobs to the community. The $67 million investment includes new production lines, equipment and a warehouse, and will help 3M more quickly meet customer demand for the company's personal safety products. The expansion of the plant is expected to create about 40 new jobs.

In January 2024, Cardinal Health announced that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology.

Products Covered:
• Topical
• Oral Drugs
• Dressings

Stages Covered:
• Mild
• Moderate
• Severe

Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary     
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 Product Analysis    
 3.7 Emerging Markets    
 3.8 Impact of Covid-19    
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
5 Global Radiodermatitis Market, By Product     
 5.1 Introduction    
 5.2 Topical    
  5.2.1 Corticosteroids   
  5.2.2 Hydrophilic Creams   
  5.2.3 Topical Antibiotics   
  5.2.4 Other Topicals   
 5.3 Oral Drugs    
 5.4 Dressings    
  5.4.1 Honey Impregnated Gauze   
  5.4.2 Hydrocolloid Dressings   
  5.4.3 Hydrogel Dressings   
  5.4.4 No Sting Barrier Film   
  5.4.5 Silicone Coated Dressings   
  5.4.6 Other Dressings    
6 Global Radiodermatitis Market, By Stage     
 6.1 Introduction    
 6.2 Mild    
 6.3 Moderate    
 6.4 Severe    
7 Global Radiodermatitis Market, By Distribution Channel     
 7.1 Introduction    
 7.2 Hospital Pharmacies    
 7.3 Retail Pharmacies    
 7.4 Online Pharmacies    
8 Global Radiodermatitis Market, By Geography     
 8.1 Introduction    
 8.2 North America    
  8.2.1 US   
  8.2.2 Canada   
  8.2.3 Mexico   
 8.3 Europe    
  8.3.1 Germany   
  8.3.2 UK   
  8.3.3 Italy   
  8.3.4 France   
  8.3.5 Spain   
  8.3.6 Rest of Europe   
 8.4 Asia Pacific    
  8.4.1 Japan   
  8.4.2 China   
  8.4.3 India   
  8.4.4 Australia   
  8.4.5 New Zealand   
  8.4.6 South Korea   
  8.4.7 Rest of Asia Pacific   
 8.5 South America    
  8.5.1 Argentina   
  8.5.2 Brazil   
  8.5.3 Chile   
  8.5.4 Rest of South America   
 8.6 Middle East & Africa    
  8.6.1 Saudi Arabia   
  8.6.2 UAE   
  8.6.3 Qatar   
  8.6.4 South Africa   
  8.6.5 Rest of Middle East & Africa   
9 Key Developments     
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 9.2 Acquisitions & Mergers    
 9.3 New Product Launch    
 9.4 Expansions    
 9.5 Other Key Strategies    
10 Company Profiling     
 10.1 3M Company    
 10.2 Acelity L.P. Inc.    
 10.3 Alliqua Biomedical, Inc.    
 10.4 B. Braun Melsungen AG    
 10.5 BMG Pharma S.p.A.    
 10.6 Cardinal Health, Inc.    
 10.7 Coloplast A/S    
 10.8 Convatec Group Plc    
 10.9 DermaRite Industries, LLC    
 10.10 GlaxoSmithKline plc    
 10.11 Hollister Incorporated    
 10.12 Integra Lifesciences Holdings Corporation    
 10.13 Medline Industries, Inc.    
 10.14 MiMedx Group, Inc.    
 10.15 Mölnlycke Health Care AB    
 10.16 Pfizer Inc.    
 10.17 Radiation Products Design Inc.    
 10.18 Smith & Nephew plc    
 10.19 Stratpharma AG    
List of Tables      
1 Global Radiodermatitis Market Outlook, By Region (2022-2030) ($MN)     
2 Global Radiodermatitis Market Outlook, By Product (2022-2030) ($MN)     
3 Global Radiodermatitis Market Outlook, By Topical (2022-2030) ($MN)     
4 Global Radiodermatitis Market Outlook, By Corticosteroids (2022-2030) ($MN)     
5 Global Radiodermatitis Market Outlook, By Hydrophilic Creams (2022-2030) ($MN)     
6 Global Radiodermatitis Market Outlook, By Topical Antibiotics (2022-2030) ($MN)     
7 Global Radiodermatitis Market Outlook, By Other Topicals (2022-2030) ($MN)     
8 Global Radiodermatitis Market Outlook, By Oral Drugs (2022-2030) ($MN)     
9 Global Radiodermatitis Market Outlook, By Dressings (2022-2030) ($MN)     
10 Global Radiodermatitis Market Outlook, By Honey Impregnated Gauze (2022-2030) ($MN)     
11 Global Radiodermatitis Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)     
12 Global Radiodermatitis Market Outlook, By Hydrogel Dressings (2022-2030) ($MN)     
13 Global Radiodermatitis Market Outlook, By No Sting Barrier Film (2022-2030) ($MN)     
14 Global Radiodermatitis Market Outlook, By Silicone Coated Dressings (2022-2030) ($MN)     
15 Global Radiodermatitis Market Outlook, By Other Dressings  (2022-2030) ($MN)     
16 Global Radiodermatitis Market Outlook, By Stage (2022-2030) ($MN)     
17 Global Radiodermatitis Market Outlook, By Mild (2022-2030) ($MN)     
18 Global Radiodermatitis Market Outlook, By Moderate (2022-2030) ($MN)     
19 Global Radiodermatitis Market Outlook, By Severe (2022-2030) ($MN)     
20 Global Radiodermatitis Market Outlook, By Distribution Channel (2022-2030) ($MN)     
21 Global Radiodermatitis Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)     
22 Global Radiodermatitis Market Outlook, By Retail Pharmacies (2022-2030) ($MN)     
23 Global Radiodermatitis Market Outlook, By Online Pharmacies (2022-2030) ($MN)     
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.      

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.